» Articles » PMID: 36715501

An Atrial Fibrillation-associated Regulatory Region Modulates Cardiac Levels and Arrhythmia Susceptibility

Overview
Journal Elife
Specialty Biology
Date 2023 Jan 30
PMID 36715501
Authors
Affiliations
Soon will be listed here.
Abstract

Heart development and rhythm control are highly Tbx5 dosage-sensitive. haploinsufficiency causes congenital conduction disorders, whereas increased expression levels of in human heart samples has been associated with atrial fibrillation (AF). We deleted the conserved mouse orthologues of two independent AF-associated genomic regions in the locus, one intronic (RE(int)) and one downstream (RE(down)) of . In both lines, we observed a modest (30%) increase of in the postnatal atria. To gain insight into the effects of slight dosage increase in vivo, we investigated the atrial transcriptional, epigenetic and electrophysiological properties of both lines. Increased atrial expression was associated with induction of genes involved in development, ion transport and conduction, with increased susceptibility to atrial arrhythmias, and increased action potential duration of atrial cardiomyocytes. We identified an AF-associated variant in the human RE(int) that increases its transcriptional activity. Expression of the AF-associated transcription factor was induced in cardiomyocytes. We found that some of the transcriptional and functional changes in the atria caused by increased expression were normalized when reducing cardiac expression in mice, indicating an interaction between these two AF genes. We conclude that modest increases in expression of dose-dependent transcription factors, caused by common regulatory variants, significantly impact on the cardiac gene regulatory network and disease susceptibility.

Citing Articles

Beyond genomic studies of congenital heart defects through systematic modelling and phenotyping.

Henderson D, Alqahtani A, Chaudhry B, Cook A, Eley L, Houyel L Dis Model Mech. 2024; 17(11).

PMID: 39575509 PMC: 11603121. DOI: 10.1242/dmm.050913.


Atrial fibrillation variant-to-gene prioritization through cross-ancestry eQTL and single-nucleus multiomic analyses.

Leblanc F, Jin X, Kang K, Lee C, Xu J, Xuan L iScience. 2024; 27(9):110660.

PMID: 39262787 PMC: 11388022. DOI: 10.1016/j.isci.2024.110660.


Context-dependent T-BOX transcription factor family: from biology to targeted therapy.

Li S, Luo X, Sun M, Wang Y, Zhang Z, Jiang J Cell Commun Signal. 2024; 22(1):350.

PMID: 38965548 PMC: 11225425. DOI: 10.1186/s12964-024-01719-2.


Tbx5 maintains atrial identity in post-natal cardiomyocytes by regulating an atrial-specific enhancer network.

Sweat M, Cao Y, Zhang X, Burnicka-Turek O, Perez-Cervantes C, Arulsamy K Nat Cardiovasc Res. 2024; 2(10):881-898.

PMID: 38344303 PMC: 10854392. DOI: 10.1038/s44161-023-00334-7.


Role of Genetic Variation in Transcriptional Regulatory Elements in Heart Rhythm.

Jonker T, Barnett P, Boink G, Christoffels V Cells. 2024; 13(1).

PMID: 38201209 PMC: 10777909. DOI: 10.3390/cells13010004.


References
1.
Gilsbach R, Schwaderer M, Preissl S, Gruning B, Kranzhofer D, Schneider P . Distinct epigenetic programs regulate cardiac myocyte development and disease in the human heart in vivo. Nat Commun. 2018; 9(1):391. PMC: 5786002. DOI: 10.1038/s41467-017-02762-z. View

2.
Moskowitz I, Pizard A, Patel V, Bruneau B, Kim J, Kupershmidt S . The T-Box transcription factor Tbx5 is required for the patterning and maturation of the murine cardiac conduction system. Development. 2004; 131(16):4107-16. DOI: 10.1242/dev.01265. View

3.
Smemo S, Campos L, Moskowitz I, Krieger J, Pereira A, Nobrega M . Regulatory variation in a TBX5 enhancer leads to isolated congenital heart disease. Hum Mol Genet. 2012; 21(14):3255-63. PMC: 3384386. DOI: 10.1093/hmg/dds165. View

4.
Quinlan A, Hall I . BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics. 2010; 26(6):841-2. PMC: 2832824. DOI: 10.1093/bioinformatics/btq033. View

5.
Kim B, Kim Y, Hwang G, Pak H, Lee S, Shim W . Action potential duration restitution kinetics in human atrial fibrillation. J Am Coll Cardiol. 2002; 39(8):1329-36. DOI: 10.1016/s0735-1097(02)01760-6. View